The effect of lead on vascular endothelium;Oddziaływanie ołowiu na śródbłonek naczyniowy

Medycyna Pracy

Volumn 54, Issue 1, 2003, Pages 87-93

  Stojek, Ewa ^a   Skoczyńska, Anna ^a,b  

^a Zawodowych Nadcisnienia T   (Poland)

^b NONE   (Poland)

Author keywords

Blood vessels; Endothelium; Lead

Indexed keywords

ENDOTHELIN; LEAD; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ATHEROGENESIS; BLOOD CLOTTING; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; HUMAN; HYPERTENSION; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; VASCULAR ENDOTHELIUM; ANIMAL; ARTERIOSCLEROSIS; CHEMICALLY INDUCED DISORDER; LEAD POISONING; METABOLISM; PATHOPHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; ENVIRONMENTAL EXPOSURE; HUMANS; HYPERTENSION; LEAD; LEAD POISONING; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 0043268041     PISSN: 04655893     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Sharp D.S., Becker C.E., Smith A.H.: Chronic low-level lead exposure. Its role in the pathogenesis of hypertension. Med. Toxicol. 1987; 2 (3): 210-232.
2. Moller L.F., Kristensen T.S.: Lead - a possible risk factor of increased blood pressure and cardiovascular disease. Ugeskrift for Laeger 1993; 155 (40): 3203-3207.
3. Khalil-Manesh F., Gonick H.C., Weiler E.W.J., Prins B., Weber M.A., Purdy R. i wsp.: Effects of chelation treatment with DMSA on lead-related blood pressure changes. Environ. Res. 1994; 65: 86-99.
4. Ding Y., Vaziri N.D., Gonick H.C.: Lead - induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ. Res. 1998; 76: 107-113.
5. Tsao D., Yu H.S., Cheng J.T., Ho C.K., Chang H.R.: The change of beta-adrenergic system in lead-induced hypertension. Toxicol. Appl. Pharmacol. 2000; 164 (2): 127-133.
6. Telisman S., Jurasovic J.: Blood pressure in relation to biomarkers of lead, cadmium, copper, zinc, and selenium in men without occupational exposure to metals. Environ. Res. 2001; 87 (2): 57-68.
7. Sharp D.S., Osterloh J., Becker C.E., Smith A.H., Holman B.L., Fisher J.M.: Elevated blood pressure in treated hypertensives with low-level lead accumulation. Arch. Environ. Health 1989; 44 (1): 18-22.
8. Niu Q., Day F.Y., Chen Y.L.: The effects of low-level lead exposure on autonomic nervous systems. Toxicology 1998; 17: 108-112.
9. Wójcik A., Brzeski Z., Sieklucka-Dziuba M.: Lead-levels in body fluids of workers automobile factory with clinically diagnosed arterial hypertension. Ann. Agric. Environ. Med. 2001; 8: 285-287.
10. Dolenc P., Staessen J.A., Lauwerys R.R., Amery A.: Short report: low-level lead exposure does not increase the blood pressure in the general population. Cadmibel Study Group. J. Hypertens. 1993 11 (5): 589-593.
11. Nordberg M., Winblad B., Fratiglioni L., Basun H.: Lead concentrations in elderly urban people related to blood pressure and mental performance: results from a population - based study. Am. J. Ind. Med. 2000; 38 (3): 290-294.
12. Weiss ST., Munoz A., Stein A., Sparrow D., Speizer F.E.: The relationship of blood lead to systolic blood pressure in a longitudinal study of policemen. Environ. Health Perspect. 1988; 78: 53-56.
13. Kort W.L., Verschoor M.A., Wibowo A.A., Van Hemmen J.J.: Occupational exposure to lead and blood pressure. A study in 105 workers. Am. J. Ind. Med. 1987; 11: 145-156.
14. Kort W.L., Zwennis W.C.: Blood lead and blood pressure: some implications for the situation in the Netherlands. Environ. Health Perspect. 1988; 78: 67-70.
15. Pocock S.J., Shaper A.G., Ashby D., Delves H.T., Clayto B.E.: The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environ. Health Perspect. 1988; 78: 23-30.
16. Navah U., Froom P., Kristal-Boneh E., Moschkovitz B., Ribak J.: Relationship of blood lead levels to blood pressure in battery workers. Arch. Environ. Health 1996; 52 (4): 324-328.
17. Santos A.C., Colacciopo S., Dal-Bo C.M., dos Santos N.A.: Occupational exposure to lead, kidney function tests, and blood pressure. Am. J. Ind. Med. 1994; 26: 635-643.
18. Wolf C., Wallnofer A., Waldhor T., Vutuc C., Meisinger V., Rudiger H.V.: Effect of lead on blood pressure in occupationally nonexposed men. Am. J. Ind. Med. 1995; 27 (6): 897-903.
19. Micciolo R., Canal L., Maranelli G., Apostoli P.: Non-occupational lead exposure and hypertension in northern Italy. Int. J. Epidemiol. 1994; 23 (2): 312-320.
20. Hu H., Aro A., Payton M., Korrick S., Sparrow S., Weiss ST., Rotnitzky A.: the relationship of bone and blood lead to hypertension. The normative aging study. JAMA 1996; 275: 1171-1176.
21. Malvezzi C.K., Moreira E.G., Vassilieff I, Vassilieff V.S., Cordellini S.: Effect of L-arginine, DMSA and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism. Brazil. J. Med. Biol. Res. 2001; 34: 1341-1346.
22. Schwartz J.: Lead, blood pressure, and cardiovascular diseases in men and woman. Environ. Health Perspect. 1991; 91: 71-75.
23. Nakhoul F., Kayne L.H., Brautbar N.: Raid hypertensiogenic effect of lead: Studies of the spontaneusly hypertensive rat. Toxicol. Ind. Health 1992, 8 (1-2): 89-92.
24. Miniuk K., Moniuszko-Jakoniuk J., Kulikowska E., Omeljaniuk N.: The interactions of copper, lead and ethanol in rats: effects on some biochemical parameters of blood. Pol. J. Pharm. 1989; 41 (3): 273-280.
25. Staessen J., Yeoman W.B., Flechter A.E., Markowe H.L., Marmot M.G., Rose G. i wsp.: Blood lead concentration, renal function and blood pressure in London civil servants. Br. J. Ind. Med. 1990; 47: 442-447.
26. Pizent A., Jurasovic J., Telisman S.: Blood pressure in relation to dietary calcium intake, alcohol consumption, blood lead, and blood cadmium in female nonsmokers. J. Trace Elem. Med. Biol. 2001; 15 (2-3): 123-130.
27. Khalil-Manesh F., Gonick H.C., Weiler E.W., Prins B., Weber M.A., Purdy M.E.: Lead-induced hypertension: possible role of endothelial factors. Am. J. Hypertens. 1993; 6: 723-729.
28. Vaziri N.D., Ding Y., Ni Z., Gonick H.C.: Altered nitric oxide metabolism and increased oxygen free radicals activity in lead - induced hypertension: effect of lazaroid therapy. Kidney Int. 1997; 52: 1042-1046.
29. Gonick H.C., Ding Y., Bondy S.C., Ni Z., Vaziri N.D.: Lead-induced hypertension : interplay of nitric oxide and reactive oxygen species. Hypertension 1997; 30: 1487-1492.
30. Shelkovnikov S.A., Gonick H.C.: Influence of lead on rat thoracic aorta contraction and relaxation. Am. J. Hypertens. 2001; 14: 873-878.
31. Vaziri N.D., Ding Y., Ni Z.: Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 1999; 34: 558-562.
32. Marques M., Millas I., Jimenez A., Garcia-Colis E., Rodriguez-Feo J.A., Velasco S. i wsp.: Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats. J. Am. Soc. Nephrol. 2001; 12: 2594-2600.
33. Kaji T., Fujiwara Y., Hoshino M., Yamamoto C., Sakamoto M., Kozuka H.: Inhibitory effect of lead on the proliferation of cultured vascular endothelial cells. Toxicology 1995; 95: 87-92.
34. Kirkpatrick C.J., Wagner M., Hermanns I.: Physiology and cell biology of the endothelium: a dynamic interface of cell communication. Int. J. Microcirc. 1997, 17: 231-240.
35. Bassenge E.: Endothelial function in different organs. Progress Cardiovasc. Dis. 1996; 39: 209-228.
36. Alexander R.W., Dzau V.J.: Vascular biology: the past 50 years. Circulation 2000; 102 (20 Supl. 4): IV112-IV116.
37. Taddei S., Virdis A., Ghiadoni L., Sudano I., Salvetti A.: Endothelial dysfunction in hypertension. J. Cardiovasc. Pharmacol. 2001; 38 Supl. 2: 11-14.
38. Adamska-Dyniewska H.: Leki hamuja̧ce enzym przekształ caja̧cy angiotensynȩ. Działanie i zastosowanie kliniczne. Towarzystwo Terapii Monitorowanej, Łodź 1996.
39. Furchgott R.F., Zawadzki J.V.: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylocholine. Nature 1980; 288: 373-376.
40. Stanford S.J., Gitlin J.M., Mitchell J.A.: Identification of two distinct vasodilator pathways activated ATP in the mesenteric bed of the rat. Br. J. Pharmacol. 2001; 133 (6): 825-832.
41. Campbell W.B., Harder D.R.: Prologue: EDHF - what is it? Am. J. Physiol. 2001; 280: 2413H-2416H.
42. Matoba T., Shimokawa H., Nakashima M., Hirakava Y., Mukai Y., Hirano K. i wsp.: Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J. Clin. Invest. 2000; 106 (12): 1521-1530.
43. Govers R., Rabelnik T.J.: Cellular regulation of endothelial nitric oxide synthase. AJP Renal Physiol. 2001; 280: 193-206.
44. Oner G., Bilgen I.: L-arginine-induced changes in the characteristics of endothelin relaxation. J. Basic Clin. Physiol. Pharmacol. 2001; 12 (1): 77-90.
45. Stroes E.: Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett. 1988; 438: 161-164.
46. Wever R.M., Lüscher T.F.: Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation 1998; 97: 108-112.
47. Sullivan J.C., Pollock D.M., Pollock J.S.: Altered nitric oxide synthase 3 distribution in mesenteric arteries of hypertensive rats. Hypertension 2002; 39: 597-602.
48. Noris M., Morigi M., Donadelli R., Aiello S., Foppolo M., Todeschini M. i wsp.: Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ. Res. 1995; 76: 536-543.
49. Toporsian M., Govindaraju K., Nagi M., Eidelman D., Thibault G., Ward M.E.: Downregulation of endothelial nitric oxide synthase in rat aorta after prolonged hipoxia in vivo. Circ. Res. 2000; 31: 86 (6): 671-675.
50. Vaziri N.D., Ding Y., Ni Z.: Compensatory up-regulation of nitric oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J. Pharm. Exp. Ther. 2001; 298 (2): 679-685.
51. Ju H., Zou R., Venema V.J., Venema R.C.: Direct interaction of the endothelial nitric oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 1997; 272: 18522-18525.
52. Jen C.J., Jhiang S.J., Chen H.I.: Cellular response to mechanical stress. Invited Review: Effects of flow on vascular endothelial intracellular calcium signaling of rat aortas ex vivo. J. Appl. Physiol. 2000; 89 (4): 1657-1669.
53. Benigni A., Remuzzi G.: Endothelin antagonists. Lancet 1999; 353: 133-138.
54. Redmond E.M., Cahill P.A., Hodges R., Zhang S., Sitzmann J.V.: Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells. J. Cell Physiol. 1996; 166 (3): 469-479.
55. Mulvany M.J.: Vascular remodeling of resistance vessels: can we define this? Cardiovasc. Res. 1999; 41: 9-13.
56. Fujiwara Y., Kaji T.: Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis. Toxicology 1999; 133 (2-3): 147-157.
57. Fujiwara Y., Watanabe S., Sakamoto M., Kaji T.: Repair of wounded monolayers of cultured vascular endothelial cells after simultaneous exposure to lead and zinc. Toxicol. Lett. 1998; 94 (3): 181-188.
58. Vaziri N.D., Liang K., Ding Y.: Increased nitric oxide inactivation by reactive oxygen species in led-induced hypertension. Kidney Int. 1999; 56: 1492-1498.
59. Marques M., Millas I., Jimenez A., Garcia-Colis E., Rodriguez-Feo J.A., Velasco S. i wsp.: Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats. J. Am. Soc. Nephrol. 2001; 12: 2594-2600.
60. Gonick H.C., Ding Y., Vaziri N.D.: Effect of low lead exposure on eicosanoid excretion in rats. Prostaglandins Other Lipid Mediat 1998; 55: 77-82.
61. Ding Y., Gonick H.C., Vaziri N.D.: Lead-induced hypertension. Increased hydroxyl radical production. Am. J. Hypertens. 2001; 14: 169-173.